BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Breast cancer AND DNAJB1, HSPF1, 3337, ENSG00000132002, P25685, Hdj1, Hsp40
41 results:

  • 1. DNAJC9 expression in basal-like and luminal A breast cancer subtypes predicts worse survival.
    Incekara O; Acun T
    Mol Biol Rep; 2023 Sep; 50(9):7275-7282. PubMed ID: 37422538
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Acceptability of a companion patient guide to support expert consensus guidelines on surveillance mammography in older breast cancer survivors.
    Freedman RA; Revette AC; Gagnon H; Perilla-Glen A; Kokoski M; Hussein SO; Leone E; Hixon N; Lovato R; Loeser W; Lin NU; Minami CA; Canin B; LeStage B; Faggen M; Poorvu PD; McKenna J; Ruddy KJ; Keating NL; Schonberg MA
    Breast Cancer Res Treat; 2022 Sep; 195(2):141-152. PubMed ID: 35908120
    [TBL] [Abstract] [Full Text] [Related]  

  • 3.
    Manunu B; Serafin AM; Akudugu JM
    Int J Radiat Biol; 2023; 99(2):292-307. PubMed ID: 35511481
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. False-negatives due to poor specimens can be prevented based on the macroscopic findings for breast Vacuum-Assisted Biopsy specimens.
    Izumori A; Takahashi M; Sasa S; Inoue H; Tangoku A; Kanematsu M; Sasa M
    J Med Invest; 2022; 69(1.2):51-64. PubMed ID: 35466146
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. A seven-autophagy-related gene signature for predicting the prognosis of differentiated thyroid carcinoma.
    Li C; Yuan Q; Xu G; Yang Q; Hou J; Zheng L; Wu G
    World J Surg Oncol; 2022 Apr; 20(1):129. PubMed ID: 35459137
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Rural-urban differences in secular trends of locoregional treatment for ductal carcinoma in situ: A patterns of care analysis.
    Riley D; Chrischilles EA; Lizarraga IM; Charlton M; Smith BJ; Lynch CF
    Cancer Med; 2022 Jun; 11(11):2284-2295. PubMed ID: 35146946
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. miR-1205/dnajb1 reverses docetaxel chemoresistance in human triple negative breast carcinoma cells via regulation of mutp53/TAp63 signaling.
    Yin Y; Zhang J; Ma T; Chen D; Lu D
    Acta Biochim Biophys Sin (Shanghai); 2022 Jan; 54(1):37-46. PubMed ID: 35130632
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. CAR-T Cells Targeting TSHR Demonstrate Safety and Potent Preclinical Activity Against Differentiated Thyroid cancer.
    Li H; Zhou X; Wang G; Hua D; Li S; Xu T; Dong M; Cui X; Yang X; Wu Y; Cai M; Liao X; Zhang T; Yang Z; Du Y; Li X
    J Clin Endocrinol Metab; 2022 Mar; 107(4):1110-1126. PubMed ID: 34751400
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. The Effect of Maternal Vitamin D Supplementation on Vitamin D Status of Exclusively breastfeeding Mothers and Their Nursing Infants: A Systematic Review and Meta-Analysis of Randomized Clinical Trials.
    Kazemain E; Ansari S; Davoodi SH; Patterson WB; Shakerinava P; Wagner CL; Amouzegar A
    Adv Nutr; 2022 Mar; 13(2):568-585. PubMed ID: 34718374
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. MicroRNAs and Heat Shock Proteins in breast cancer Biology.
    Yildiz MT; Tutar L; Giritlioğlu NI; Bayram B; Tutar Y
    Methods Mol Biol; 2022; 2257():293-310. PubMed ID: 34432285
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Explorations of ATP-Binding Cassette Transporters and Apoptosis Signal Pathways of 2-Hydroxyanthraquinone Substituted Cyclotriphosphazenes in MCF-7 and DLD-1 Cell Lines.
    Yazgan B; Mesci S; Bayık N; Akşahin M; Çiftçi GY; Yıldırım T
    Anticancer Agents Med Chem; 2022; 22(6):1124-1138. PubMed ID: 34353271
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. High expression of
    Ileri FC; Acun T
    Biomark Med; 2021 Aug; 15(12):941-950. PubMed ID: 34236236
    [No Abstract]    [Full Text] [Related]  

  • 13. Dual roles of HSP70 chaperone HSPA1 in quality control of nascent and newly synthesized proteins.
    Tian G; Hu C; Yun Y; Yang W; Dubiel W; Cheng Y; Wolf DA
    EMBO J; 2021 Jul; 40(13):e106183. PubMed ID: 34010456
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Multipanel assay of 17 tumor-associated antibodies for serological detection of stage 0/I breast cancer.
    Sumazaki M; Ogata H; Nabeya Y; Kuwajima A; Hiwasa T; Shimada H
    Cancer Sci; 2021 May; 112(5):1955-1962. PubMed ID: 33605508
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Coffee consumption and cancer risk in African Americans from the Southern Community Cohort Study.
    Schmit SL; Nwogu O; Matejcic M; DeRenzis A; Lipworth L; Blot WJ; Raskin L
    Sci Rep; 2020 Oct; 10(1):17907. PubMed ID: 33087743
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Development of a Multiplex Bead-Based Method for the Microquantitation of
    Lee M; Taş İ; Zhou R; Jung SC; Kim K; Kim H
    J Nanosci Nanotechnol; 2020 Sep; 20(9):5819-5822. PubMed ID: 32331188
    [No Abstract]    [Full Text] [Related]  

  • 17. Evaluation of the Role of Human DNAJAs in the Response to Cytotoxic Chemotherapeutic Agents in a Yeast Model System.
    Whitmore A; Freeny D; Sojourner SJ; Miles JS; Graham WM; Flores-Rozas H
    Biomed Res Int; 2020; 2020():9097638. PubMed ID: 32149145
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Downregulation of DNAJC10 (ERDJ5) is associated with poor survival in breast cancer.
    Acun T; Senses KM
    Breast Cancer; 2020 May; 27(3):483-489. PubMed ID: 31902119
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Systems-level Analysis Reveals Multiple Modulators of Epithelial-mesenchymal Transition and Identifies DNAJB4 and CD81 as Novel Metastasis Inducers in breast cancer.
    Uretmen Kagiali ZC; Sanal E; Karayel Ö; Polat AN; Saatci Ö; Ersan PG; Trappe K; Renard BY; Önder TT; Tuncbag N; Şahin Ö; Ozlu N
    Mol Cell Proteomics; 2019 Sep; 18(9):1756-1771. PubMed ID: 31221721
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Targeted Profiling of Heat Shock Proteome in Radioresistant breast cancer Cells.
    Miao W; Fan M; Huang M; Li JJ; Wang Y
    Chem Res Toxicol; 2019 Feb; 32(2):326-332. PubMed ID: 30596229
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 3.